Strategy

Long term, our vision is to build a company with the following characteristics

• A diversified pipeline of differentiated pharmaceutical products with strong patient benefits.
• A technology focus on genetic chemistry, as the fundamental source of differentiated products.
• An therapeutic area emphasis on cardiovascular/metabolic and infectious diseases.
• An alertness to product and market opportunities in emerging markets in addition to those in the West.
• An international business model with pragmatic, aggressive and cost-effective implementation.